NCT05951322

Extra Corporeal Shock Wave Versus Phonophoresis in Sub Acromial Impingement Syndrome.

Completed Phase 3 Last updated 19 July 2023

What this trial tests

Phase 3 trial testing Shockwave therapy in Sub Acromial Impingement Syndrome in 30 participants. Completed in 8 June 2023.

Timeline

8 January 2023

Primary endpoint
8 June 2023

8 June 2023

Quick facts

Lead sponsor	Prince Sattam Bin Abdulaziz University
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	30
Start date	8 January 2023
Primary completion	8 June 2023
Estimated completion	8 June 2023
Sites	1 location across Saudi Arabia

Drugs / interventions tested

• Shockwave therapy
• Phonophoresis

Conditions studied

• Sub Acromial Impingement Syndrome — all drugs for Sub Acromial Impingement Syndrome →

Sponsor

Prince Sattam Bin Abdulaziz University

Who can join

Adults 30 to 50, any sex, with Sub Acromial Impingement Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

shoulder sub acromial impingement syndrome is an encroachment of subacrormial tissues, rotator cuff, subacrormial bursa, and the long head of the biceps tendon, as a result of narrowing of the subacrormial space. Activities requiring repetitive or sustained use of the arms over head often predispose the rotator cuff tendon to injury. Hence the objective of the study is to examine the influence of extra corporeal Shock wave versus phonophoresis on pain severity and functional disability in patients with sub acromial impingement syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.